首站-论文投稿智能助手
典型文献
Diallyl disulfide and diallyl trisulfide in garlic as novel therapeutic agents to overcome drug resistance in breast cancer
文献摘要:
Breast cancer is one of the leading causes of cancer-related deaths in women worldwide.It is a cancer that originates from the mammary ducts and involves mutations in multiple genes.Recently,the treatment of breast cancer has become increasingly challenging owing to the increase in tumor het-erogeneity and aggressiveness,which gives rise to therapeutic resistance.Epidemiological,population-based,and hospital-based case-control studies have demonstrated an association between high intake of certain Allium vegetables and a reduced risk in the development of breast cancer.Diallyl disulfide(DADS)and diallyl trisulfide(DATS)are the main allyl sulfur compounds present in garlic,and are known to exhibit anticancer activity as they interfere with breast cancer cell proliferation,tumor metastasis,and angiogenesis.The present review highlights multidrug resistance mechanisms and their signaling pathways in breast cancer.This review discusses the potential anticancer activities of DADS and DATS,with emphasis on drug resistance in triple-negative breast cancer(TNBC).Understanding the anticancer activities of DADS and DATS provides insights into their potential in targeting drug resistance mecha-nisms of TNBC,especially in clinical studies.
文献关键词:
作者姓名:
RamaRao Malla;Rakshmitha Marni;Anindita Chakraborty;Mohammad Amjad Kamal
作者机构:
Cancer Biology Lab,Department of Biochemistry and Bioinformatics,Institute of Science,Gandhi Institute of Technology and Management,Visakhapatnam,530045,India;Radiation Biology,UGC-DAE-CSR,Kolkata Centre,Kolkata,700098,India;King Fahd Medical Research Center,King Abdulaziz University,Jeddah,21589,Saudi Arabia;Enzymoics,Hebersham,Novel Global Community Educational Foundation,New South Wales,2770,Australia
引用格式:
[1]RamaRao Malla;Rakshmitha Marni;Anindita Chakraborty;Mohammad Amjad Kamal-.Diallyl disulfide and diallyl trisulfide in garlic as novel therapeutic agents to overcome drug resistance in breast cancer)[J].药物分析学报(英文),2022(02):221-231
A类:
Diallyl,trisulfide,erogeneity
B类:
disulfide,diallyl,garlic,novel,therapeutic,agents,overcome,resistance,breast,Breast,one,leading,causes,related,deaths,women,worldwide,It,that,originates,from,mammary,ducts,involves,mutations,multiple,Recently,treatment,become,increasingly,challenging,owing,increase,tumor,het,aggressiveness,which,gives,rise,Epidemiological,population,hospital,case,control,studies,have,demonstrated,association,between,intake,certain,Allium,vegetables,reduced,risk,development,DADS,DATS,are,main,sulfur,compounds,present,known,exhibit,anticancer,activity,they,interfere,cell,proliferation,metastasis,angiogenesis,review,highlights,multidrug,mechanisms,their,signaling,pathways,This,discusses,potential,activities,emphasis,triple,negative,TNBC,Understanding,provides,insights,into,targeting,especially,clinical
AB值:
0.543134
相似文献
A novel PI3K inhibitor XH30 suppresses orthotopic glioblastoma and brain metastasis in mice models
Ming Ji;Dongjie Wang;Songwen Lin;Chunyang Wang;Ling Li;Zhihui Zhang;Jing Jin;Deyu Wu;Yi Dong;Heng Xu;Duo Lu;Xiaoguang Chen-State Key Laboratory of Bioactive Substances and Functions of Natural Medicines,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China;Beijing Key Laboratory of Non-Clinical Drug Metabolism and PK/PD Study,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China;Beijing Key Laboratory of New Drug Mechanisms and Pharmacological Evaluation Study,Institute of Materia Medica,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100050,China
Acquisition of taxane resistance by p53 inactivation in ovarian cancer cells
Changfa Shu;Xi Zheng;Alafate Wuhafu;Danielle Cicka;Sean Doyle;Qiankun Niu;Dacheng Fan;Kun Qian;Andrey A.Ivanov;Yuhong Du;Xiulei Mo;Haian Fu-Department of Pharmacology and Chemical Biology,Emory University School of Medicine,Atlanta,GA 30322,USA;Department of Gynecology and Obstetrics,The Third Xiangya Hospital of Central South University,Changsha 410013,China;Cancer Institute,the Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310052,China;The First Affiliated Hospital,Medical School of Xi'an Jiaotong University,Xi'an 710061,China;Emory Chemical Biology Discovery Center,Emory University School of Medicine,Atlanta,GA 30322,USA;Department of Hematology and Medical Oncology and Winship Cancer Institute,Emory University,Atlanta,GA 30322,USA
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。